Kawano, M.; Yano, Y.; Yamamoto, A.; Yasutomi, E.; Inoue, Y.; Kitadai, J.; Yoshida, R.; Matsuura, T.; Shiomi, Y.; Ueda, Y.;
et al. Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy. Diagnostics 2024, 14, 815.
https://doi.org/10.3390/diagnostics14080815
AMA Style
Kawano M, Yano Y, Yamamoto A, Yasutomi E, Inoue Y, Kitadai J, Yoshida R, Matsuura T, Shiomi Y, Ueda Y,
et al. Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy. Diagnostics. 2024; 14(8):815.
https://doi.org/10.3390/diagnostics14080815
Chicago/Turabian Style
Kawano, Miki, Yoshihiko Yano, Atsushi Yamamoto, Eiichiro Yasutomi, Yuta Inoue, Jun Kitadai, Ryutaro Yoshida, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda,
and et al. 2024. "Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy" Diagnostics 14, no. 8: 815.
https://doi.org/10.3390/diagnostics14080815
APA Style
Kawano, M., Yano, Y., Yamamoto, A., Yasutomi, E., Inoue, Y., Kitadai, J., Yoshida, R., Matsuura, T., Shiomi, Y., Ueda, Y., & Kodama, Y.
(2024). Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy. Diagnostics, 14(8), 815.
https://doi.org/10.3390/diagnostics14080815
